img

Age Related Macular Degeneration (AMD)


Published on: 2024-01-04 | No of Pages : 178 | Industry : Pharma & Healthcare

Publisher : MRA Reports | Format : PDF&Excel

Age Related Macular Degeneration (AMD)

The global Age Related Macular Degeneration (AMD) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on MRA Reports newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

Bayer

F. HoffmannLa Roche

Regeneron

Novartis

Valeant

Pfizer



By Types

Wet AMD

Dry AMD



By Applications

Men

Woman



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue

1.5 Market Analysis by Type

1.5.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Wet AMD

1.5.3 Dry AMD

1.6 Market by Application

1.6.1 Global Age Related Macular Degeneration (AMD) Market Share by Application: 2022-2027

1.6.2 Men

1.6.3 Woman

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Age Related Macular Degeneration (AMD) Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Age Related Macular Degeneration (AMD) Market Players Profiles

3.1 Bayer

3.1.1 Bayer Company Profile

3.1.2 Bayer Age Related Macular Degeneration (AMD) Product Specification

3.1.3 Bayer Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 F. HoffmannLa Roche

3.2.1 F. HoffmannLa Roche Company Profile

3.2.2 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Specification

3.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Regeneron

3.3.1 Regeneron Company Profile

3.3.2 Regeneron Age Related Macular Degeneration (AMD) Product Specification

3.3.3 Regeneron Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Novartis

3.4.1 Novartis Company Profile

3.4.2 Novartis Age Related Macular Degeneration (AMD) Product Specification

3.4.3 Novartis Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Valeant

3.5.1 Valeant Company Profile

3.5.2 Valeant Age Related Macular Degeneration (AMD) Product Specification

3.5.3 Valeant Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Pfizer

3.6.1 Pfizer Company Profile

3.6.2 Pfizer Age Related Macular Degeneration (AMD) Product Specification

3.6.3 Pfizer Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Age Related Macular Degeneration (AMD) Market Competition by Market Players

4.1 Global Age Related Macular Degeneration (AMD) Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Market Players (2016-2021)

4.3 Global Age Related Macular Degeneration (AMD) Average Price by Market Players (2016-2021)

5 Global Age Related Macular Degeneration (AMD) Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.1.2 Age Related Macular Degeneration (AMD) Key Players in North America (2016-2021)

5.1.3 North America Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.1.4 North America Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.2.2 Age Related Macular Degeneration (AMD) Key Players in East Asia (2016-2021)

5.2.3 East Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.2.4 East Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.3.2 Age Related Macular Degeneration (AMD) Key Players in Europe (2016-2021)

5.3.3 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.3.4 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.4.2 Age Related Macular Degeneration (AMD) Key Players in South Asia (2016-2021)

5.4.3 South Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.4.4 South Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.5.2 Age Related Macular Degeneration (AMD) Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.5.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.6.2 Age Related Macular Degeneration (AMD) Key Players in Middle East (2016-2021)

5.6.3 Middle East Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.6.4 Middle East Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.7.2 Age Related Macular Degeneration (AMD) Key Players in Africa (2016-2021)

5.7.3 Africa Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.7.4 Africa Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.8.2 Age Related Macular Degeneration (AMD) Key Players in Oceania (2016-2021)

5.8.3 Oceania Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.8.4 Oceania Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.9.2 Age Related Macular Degeneration (AMD) Key Players in South America (2016-2021)

5.9.3 South America Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.9.4 South America Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Age Related Macular Degeneration (AMD) Market Size (2016-2021)

5.10.2 Age Related Macular Degeneration (AMD) Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021)

5.10.4 Rest of the World Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021)

6 Global Age Related Macular Degeneration (AMD) Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Age Related Macular Degeneration (AMD) Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Age Related Macular Degeneration (AMD) Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Age Related Macular Degeneration (AMD) Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Age Related Macular Degeneration (AMD) Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Age Related Macular Degeneration (AMD) Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Age Related Macular Degeneration (AMD) Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Age Related Macular Degeneration (AMD) Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Age Related Macular Degeneration (AMD) Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Age Related Macular Degeneration (AMD) Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Age Related Macular Degeneration (AMD) Consumption by Countries

7 Global Age Related Macular Degeneration (AMD) Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Age Related Macular Degeneration (AMD) (2022-2027)

7.2 Global Forecasted Revenue of Age Related Macular Degeneration (AMD) (2022-2027)

7.3 Global Forecasted Price of Age Related Macular Degeneration (AMD) (2022-2027)

7.4 Global Forecasted Production of Age Related Macular Degeneration (AMD) by Region (2022-2027)

7.4.1 North America Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.3 Europe Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.7 Africa Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.9 South America Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Age Related Macular Degeneration (AMD) Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Age Related Macular Degeneration (AMD) by Application (2022-2027)

8 Global Age Related Macular Degeneration (AMD) Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.2 East Asia Market Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.3 Europe Market Forecasted Consumption of Age Related Macular Degeneration (AMD) by Countriy

8.4 South Asia Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.5 Southeast Asia Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.6 Middle East Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.7 Africa Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.8 Oceania Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.9 South America Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

8.10 Rest of the world Forecasted Consumption of Age Related Macular Degeneration (AMD) by Country

9 Global Age Related Macular Degeneration (AMD) Sales by Type (2016-2027)

9.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2016-2021)

9.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2022-2027)

10 Global Age Related Macular Degeneration (AMD) Consumption by Application (2016-2027)

10.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2016-2021)

10.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2022-2027)

11 Global Age Related Macular Degeneration (AMD) Manufacturing Cost Analysis

11.1 Age Related Macular Degeneration (AMD) Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Age Related Macular Degeneration (AMD)

12 Global Age Related Macular Degeneration (AMD) Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Age Related Macular Degeneration (AMD) Distributors List

12.3 Age Related Macular Degeneration (AMD) Customers

12.4 Age Related Macular Degeneration (AMD) Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue (US$ Million) 2016-2021

Table 6. Global Age Related Macular Degeneration (AMD) Market Size by Type (US$ Million): 2022-2027

Table 7. Wet AMD Features

Table 8. Dry AMD Features

Table 16. Global Age Related Macular Degeneration (AMD) Market Size by Application (US$ Million): 2022-2027

Table 17. Men Case Studies

Table 18. Woman Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Age Related Macular Degeneration (AMD) Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Age Related Macular Degeneration (AMD) Market Growth Strategy

Table 46. Age Related Macular Degeneration (AMD) SWOT Analysis

Table 47. Bayer Age Related Macular Degeneration (AMD) Product Specification

Table 48. Bayer Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product Specification

Table 50. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Regeneron Age Related Macular Degeneration (AMD) Product Specification

Table 52. Regeneron Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Novartis Age Related Macular Degeneration (AMD) Product Specification

Table 54. Table Novartis Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Valeant Age Related Macular Degeneration (AMD) Product Specification

Table 56. Valeant Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Pfizer Age Related Macular Degeneration (AMD) Product Specification

Table 58. Pfizer Age Related Macular Degeneration (AMD) Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Age Related Macular Degeneration (AMD) Production Capacity by Market Players

Table 148. Global Age Related Macular Degeneration (AMD) Production by Market Players (2016-2021)

Table 149. Global Age Related Macular Degeneration (AMD) Production Market Share by Market Players (2016-2021)

Table 150. Global Age Related Macular Degeneration (AMD) Revenue by Market Players (2016-2021)

Table 151. Global Age Related Macular Degeneration (AMD) Revenue Share by Market Players (2016-2021)

Table 152. Global Market Age Related Macular Degeneration (AMD) Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 155. North America Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 157. North America Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 159. East Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 162. East Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 164. East Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 166. Europe Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 169. Europe Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 171. Europe Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 173. South Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 176. South Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 178. South Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 180. Southeast Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 183. Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 185. Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 187. Middle East Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 190. Middle East Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 192. Middle East Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 194. Africa Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 197. Africa Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 199. Africa Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 201. Oceania Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 204. Oceania Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 206. Oceania Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 208. South America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 211. South America Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 213. South America Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 215. Rest of the World Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Age Related Macular Degeneration (AMD) Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Age Related Macular Degeneration (AMD) Market Share (2016-2021)

Table 218. Rest of the World Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Age Related Macular Degeneration (AMD) Market Share by Type (2016-2021)

Table 220. Rest of the World Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Age Related Macular Degeneration (AMD) Market Share by Application (2016-2021)

Table 222. North America Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 223. East Asia Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 224. Europe Age Related Macular Degeneration (AMD) Consumption by Region (2016-2021)

Table 225. South Asia Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 226. Southeast Asia Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 227. Middle East Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 228. Africa Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 229. Oceania Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 230. South America Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 231. Rest of the World Age Related Macular Degeneration (AMD) Consumption by Countries (2016-2021)

Table 232. Global Age Related Macular Degeneration (AMD) Production Forecast by Region (2022-2027)

Table 233. Global Age Related Macular Degeneration (AMD) Sales Volume Forecast by Type (2022-2027)

Table 234. Global Age Related Macular Degeneration (AMD) Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Age Related Macular Degeneration (AMD) Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Age Related Macular Degeneration (AMD) Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Age Related Macular Degeneration (AMD) Sales Price Forecast by Type (2022-2027)

Table 238. Global Age Related Macular Degeneration (AMD) Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Age Related Macular Degeneration (AMD) Consumption Value Forecast by Application (2022-2027)

Table 240. North America Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 241. East Asia Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 242. Europe Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 243. South Asia Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 245. Middle East Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 246. Africa Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 247. Oceania Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 248. South America Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027 by Country

Table 250. Global Age Related Macular Degeneration (AMD) Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2016-2021)

Table 252. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2022-2027)

Table 254. Global Age Related Macular Degeneration (AMD) Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2016-2021)

Table 256. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2022-2027)

Table 258. Age Related Macular Degeneration (AMD) Distributors List

Table 259. Age Related Macular Degeneration (AMD) Customers List





Figure 1. Product Figure

Figure 2. Global Age Related Macular Degeneration (AMD) Market Share by Type: 2021 VS 2027

Figure 3. Global Age Related Macular Degeneration (AMD) Market Share by Application: 2021 VS 2027

Figure 4. North America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 6. North America Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 7. United States Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 8. Canada Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 12. China Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 13. Japan Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 15. Europe Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 16. Europe Age Related Macular Degeneration (AMD) Consumption Market Share by Region in 2021

Figure 17. Germany Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 19. France Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 20. Italy Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 21. Russia Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 22. Spain Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 25. Poland Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 27. South Asia Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 28. India Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 30. Southeast Asia Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 31. Indonesia Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 37. Middle East Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 38. Turkey Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 40. Iran Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 42. Africa Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 43. Africa Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 44. Nigeria Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 47. Oceania Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 48. Australia Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 49. South America Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 50. South America Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 51. Brazil Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Age Related Macular Degeneration (AMD) Consumption and Growth Rate

Figure 54. Rest of the World Age Related Macular Degeneration (AMD) Consumption Market Share by Countries in 2021

Figure 55. Global Age Related Macular Degeneration (AMD) Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Age Related Macular Degeneration (AMD) Price and Trend Forecast (2022-2027)

Figure 58. North America Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 59. North America Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 75. South America Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Age Related Macular Degeneration (AMD) Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Age Related Macular Degeneration (AMD) Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 79. East Asia Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 80. Europe Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 81. South Asia Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 82. Southeast Asia Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 83. Middle East Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 84. Africa Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 85. Oceania Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 86. South America Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 87. Rest of the world Age Related Macular Degeneration (AMD) Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Age Related Macular Degeneration (AMD)

Figure 89. Manufacturing Process Analysis of Age Related Macular Degeneration (AMD)

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Age Related Macular Degeneration (AMD) Supply Chain Analysis